Source intake
33 alerts todayOfficial releases, SEC filings, agency material, and monitored public sources enter as timestamped alerts before any trade narrative is written.
A live diligence surface for the alpha lab: sourcing, decision gates, paper trades, lane productivity, and risk controls from the same artifacts the operator uses.
The platform is designed to prove process discipline before P&L scale: no source, no ticket; no risk expression, no paper trade; no outcome attribution, no lane promotion.
Official releases, SEC filings, agency material, and monitored public sources enter as timestamped alerts before any trade narrative is written.
Ticker identity, source ownership, novelty, tradeability, and no-chase boundaries are checked before paid review is allowed.
The current RYTM long-vol setup has source support, ORATS context, and a dated catalyst, but it remains blocked until the missing risk gates are explicit.
No paper or live entry is allowed without position sizing, max loss, stop logic, event time stop, and liquidity context.
Approved ideas move to a $100k realistic paper ledger using whole shares or whole option contracts, with skipped minimum-size trades counted honestly.
Position sync, review sweeps, active-shadow watch, and dashboard publication timers keep marks, downgrades, time stops, and profit takes visible.
Every closed paper mark stores P&L, alpha versus benchmark, process result, failure bucket, and the exact exit reason.
The lane scorecard keeps Edge Hunter active and caps expensive lanes that produce weak useful-ticket yield.
This is the page a risk committee should see: the candidate, what supports it, and the exact reasons it has not been allowed into paper yet.
RYTM event-vol edge: Rhythm Pharmaceuticals to Announce Interim Six-Month Phase 2 Results Evaluating Setmelanotide in Patients with Prader-Willi Syndrome
Primary trade-eligible source
Detected by alpha:edge-hunter from FMP_PRESS_RELEASE. COMPANY_PRESS_RELEASE source scored 7.2: regulatory/clinical decision; earnings/result language; multiple hard numbers
Biotech regulatory: Biotech regulatory keywords matched the primary source.
Biotech regulatory does not need a single contract-size ratio, but the source contains operating/control/event proof.
IV30 +77.9%; implied move +17.3%; contango -7.0%
FMP_QUOTE $88.38; change +0.8%
Reference $88.38; threshold +13.8%
Before entry, review the company webcast/transcript or wait for FMP transcript ingestion.
Realistic paper ledger starts with $100,000, sizes from current paper equity, rounds equities to whole shares and options to whole contracts, and counts skipped minimum-size trades as $0 P&L.
The current lack of open paper trades is not hidden. The process is blocking a candidate because risk expression is incomplete, while paid API usage and old-system isolation remain visible.
0 live trades and 0 open positions in the published dashboard.
RYTM is blocked from paper because position sizing and max loss are not written, even though source, ORATS, tradeability, and time stop checks passed.
1,252 paid calls in the last 24h; heartbeat flags PAID_CALL_SPIKE.
Old public-site paid APIs are paused while the alpha lab owns paid research calls.
OpenClaw is inactive and disabled; this page is the Moods Alpha paper process, not live crypto execution.
17 outcome records, 17 closed paper marks, and visible failure buckets for misses and downgrades.
Each lane must earn its cost. The latest scorecard keeps active lanes visible and shows which monitors are capped because they produced too many no-trade or low-yield outputs.
| Lane | Action | Tickets | Useful | Paid calls | No-trade | Top reject reason |
|---|---|---|---|---|---|---|
| EDGE HUNTERLane has active review/shadow/live work. | KEEP ACTIVE | 14 | 1 | 271 / useful | +93% | - |
| DILUTION SHOCKInsufficient recent evidence for promotion or removal. | WATCH | 7 | 0 | 0 | +100% | - |
| CONTRACT AWARD MATERIALInsufficient recent evidence for promotion or removal. | WATCH | 2 | 0 | 0 | +100% | - |
| CONTROL PRESSUREHigh paid spend with zero useful tickets in the window. | CAP HARD | 5 | 0 | 98 | +100% | - |
| EVENT HUNTERHigh paid spend with zero useful tickets in the window. | CAP HARD | 4 | 0 | 139 | +100% | - |
| PRE EARNINGS BREADCRUMBPaid calls produced no tickets. | CAP | 0 | 0 | 8 | 0% | - |
| ALPHA:UNIVERSE-BUILDPaid calls produced no tickets. | CAP | 0 | 0 | 6 | 0% | - |
| KIMI ADJUDICATEPaid calls produced no tickets. | CAP | 0 | 0 | 6 | 0% | - |
| ALPHA:OPERATOR-OPTIONS-SANITY-CHECKPaid calls produced no tickets. | CAP | 0 | 0 | 2 | 0% | - |
The page ends with marks, not slogans. A fund can inspect what traded, what closed, what made money, and what the process called the exit.
| Marked | Paper trade | Result | P&L | Alpha | Exit logic |
|---|---|---|---|---|---|
| Jun 11, 05:45 PM UTC | EQPT EQUITY_SHORTEXECUTED WHOLE SHARES | MISS | -0.2% | -0.3% | MACRO OVERWHELMED |
| Jun 9, 01:35 PM UTC | AVOEXECUTED WHOLE SHARES | HIT | +0.4% | +0.4% | NONE |
| Jun 8, 06:17 PM UTC | ROADEXECUTED WHOLE SHARES | MISS | -0.1% | -0.1% | GOOD NO TRADE |
| Jun 8, 01:30 PM UTC | BGS EQUITY_SHORTEXECUTED WHOLE SHARES | HIT | +0.1% | +0.2% | NONE |
| Jun 5, 02:18 PM UTC | AIBEXECUTED WHOLE SHARES | HIT | +0.2% | +0.2% | NONE |
| Jun 3, 06:21 PM UTC | RBRKEXECUTED WHOLE SHARES | HIT | +0.1% | +0.1% | NONE |
| Jun 3, 04:18 PM UTC | KBREXECUTED WHOLE SHARES | HIT | +0.0% | +0.0% | NONE |
| Jun 2, 02:00 PM UTC | ASYS EQUITY_SHORTEXECUTED WHOLE SHARES | MISS | -0.2% | -0.2% | MACRO OVERWHELMED |
Hetzner timers: 10 configured, failed services: 0.